TFX (STOCKS)
Teleflex Incorporated
$130.090000
-0.390000 (-0.30%)
Prev close: $130.480000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Jason Weidman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,754.68M
- Employees
- 14,100
- P/E (TTM)
- -5.70
- P/B (TTM)
- 1.87
- Dividend Yield
- 104.23%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
5
Buy
11
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$1.39 | $1.22 | +0.1719 | +14.11% |
|
Dec 2025 (Q4)
|
$1.93 | $3.77 | -1.8417 | -48.83% |
|
Sep 2025 (Q3)
|
$3.67 | $3.42 | +0.2534 | +7.42% |
|
Sep 2000 (Q3)
|
$0.55 | $0.56 | -0.0075 | -1.35% |
Financial Statements
| Revenues | $2.13B |
| Benefits Costs and Expenses | $2.12B |
| Cost Of Revenue | $1.31B |
| Costs And Expenses | $2.12B |
| Gross Profit | $1.17B |
| Operating Expenses | $1.11B |
| Selling, General, and Administrative Expenses | $723.47M |
| Depreciation and Amortization | $164.15M |
| Research and Development | $152.76M |
| Operating Income/Loss | $62.76M |
| Income/Loss From Continuing Operations After Tax | $1.36M |
| Income/Loss From Continuing Operations Before Tax | -$310.71M |
| Income/Loss From Discontinued Operations Net Of Tax | -$1.01B |
| Income Tax Expense/Benefit | -$46.81M |
| Income Tax Expense/Benefit, Deferred | -$113.57M |
| Net Income/Loss | -$1.01B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$1.01B |
| Net Income/Loss Available To Common Stockholders, Basic | -$1.01B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$22.80 |
| Diluted Earnings Per Share | -$22.80 |
| Basic Average Shares | 132,630,000 |
| Diluted Average Shares | 132,795,000 |
| Assets | $6.78B |
| Current Assets | $1.86B |
| Inventory | $380.86M |
| Other Current Assets | $1.48B |
| Noncurrent Assets | $4.92B |
| Fixed Assets | $476.96M |
| Intangible Assets | $1.49B |
| Other Non-current Assets | $2.96B |
| Liabilities | $3.70B |
| Current Liabilities | $728.05M |
| Accounts Payable | $143.63M |
| Wages | $103.35M |
| Other Current Liabilities | $481.08M |
| Noncurrent Liabilities | $2.97B |
| Equity | $3.08B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.08B |
| Liabilities And Equity | $6.78B |
| Net Cash Flow From Operating Activities | $316.61M |
| Net Cash Flow From Operating Activities, Continuing | $115.62M |
| Net Cash Flow From Operating Activities, Discontinued | $200.99M |
| Net Cash Flow From Investing Activities | -$904.40M |
| Net Cash Flow From Investing Activities, Continuing | -$864.52M |
| Net Cash Flow From Investing Activities, Discontinued | -$39.87M |
| Net Cash Flow From Financing Activities | $626.08M |
| Net Cash Flow From Financing Activities, Continuing | $626.08M |
| Net Cash Flow | $61.46M |
| Net Cash Flow, Continuing | -$122.83M |
| Net Cash Flow, Discontinued | $161.11M |
| Comprehensive Income/Loss | -$998.87M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$1.03B |
| Other Comprehensive Income/Loss | $9.93M |